PRINCESSSHIELLA VANORD: Open Payments
NPI 1396386553 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,179 in 152 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $2,778 · 2025 $3,179
Food & beverage: $3,179
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $964 |
| PFIZER INC. | 20 | $412 |
| Janssen Biotech, Inc. | 26 | $372 |
| Ardelyx, Inc. | 12 | $291 |
| Daiichi Sankyo Inc. | 11 | $245 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $215 |
| Madrigal Pharmaceuticals | 4 | $187 |
| Phathom Pharmaceuticals, Inc. | 5 | $142 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $120 |
| Lilly USA, LLC | 2 | $50 |
Products named: RINVOQ, TREMFYA, VELSIPITY, IBSRELA, INJECTAFER, SKYRIZI, REZDIFFRA, ENTYVIO.
Industry payments across PA — which companies pay providers there.
